Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1 | Monaldi Archives for Chest Disease

Current Issue

Vol. 79 No. 3-4 (2013)

30 December 2013

View this Issue

Impact Factor 2024

Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1

Published: 30 December 2013

Editorial

Roflumilast: the fourth Mousquetaire in COPD pharmacological treatment

Bruno Balbi

https://doi.org/10.4081/monaldi.2013.26

1130

PDF: 675
- PDF

Reviews

The use of roflumilast in COPD: a review

Andrea Zanini, Francesca Cherubino, Patrizia Pignatti

https://doi.org/10.4081/monaldi.2013.27

1100

PDF: 726
- PDF

Case Reports

Roflumilast is safe and effective in improving symptoms and lung function in severe COPD

Matteo Bonini, Paolo Palange

https://doi.org/10.4081/monaldi.2013.28

1121

PDF: 702
- PDF
Two cases of COPD benefitting from therapy with roflumilast

Chiara Francesca Carraro

https://doi.org/10.4081/monaldi.2013.29

1008

PDF: 744
- PDF
Roflumilast succeeds where traditional therapy fails: a case report

Gabriella Guarnieri

https://doi.org/10.4081/monaldi.2013.30

927

PDF: 679
- PDF
A case report of roflumilast in an elderly COPD patient: improving exercise capacity to improve quality of life

Daniela Parola, Ambra Castagnacci, Sara Salvati

https://doi.org/10.4081/monaldi.2013.31

1185

PDF: 725
- PDF
Roflumilast is effective in reducing COPD related exacerbations and improving CAT score

Biagio Polla

https://doi.org/10.4081/monaldi.2013.32

1002

PDF: 685
- PDF
Significant gas-exchange improvements reported after roflumilast in two cases of severe COPD

Bruno Sposato

https://doi.org/10.4081/monaldi.2013.33

799

PDF: 710
- PDF

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy